chr17-74842541-CTG-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000835.6(GRIN2C):c.3594_3595del(p.Tyr1198Ter) variant causes a stop gained, frameshift change. The variant allele was found at a frequency of 0.0000309 in 777,670 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
GRIN2C
NM_000835.6 stop_gained, frameshift
NM_000835.6 stop_gained, frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.51
Genes affected
GRIN2C (HGNC:4587): (glutamate ionotropic receptor NMDA type subunit 2C) This gene encodes a subunit of the N-methyl-D-aspartate (NMDA) receptor, which is a subtype of ionotropic glutamate receptor. NMDA receptors are found in the central nervous system, are permeable to cations and have an important role in physiological processes such as learning, memory, and synaptic development. The receptor is a tetramer of different subunits (typically heterodimer of subunit 1 with one or more of subunits 2A-D), forming a channel that is permeable to calcium, potassium, and sodium, and whose properties are determined by subunit composition. Alterations in the subunit composition of the receptor are associated with pathophysiological conditions such as Parkinson's disease, Alzheimer's disease, depression, and schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRIN2C | NM_000835.6 | c.3594_3595del | p.Tyr1198Ter | stop_gained, frameshift_variant | 13/13 | ENST00000293190.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRIN2C | ENST00000293190.10 | c.3594_3595del | p.Tyr1198Ter | stop_gained, frameshift_variant | 13/13 | 1 | NM_000835.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000992 AC: 15AN: 151208Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
15
AN:
151208
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000329 AC: 8AN: 242992Hom.: 0 AF XY: 0.00000753 AC XY: 1AN XY: 132724
GnomAD3 exomes
AF:
AC:
8
AN:
242992
Hom.:
AF XY:
AC XY:
1
AN XY:
132724
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000144 AC: 9AN: 626346Hom.: 0 AF XY: 0.00000879 AC XY: 3AN XY: 341190
GnomAD4 exome
AF:
AC:
9
AN:
626346
Hom.:
AF XY:
AC XY:
3
AN XY:
341190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000991 AC: 15AN: 151324Hom.: 0 Cov.: 34 AF XY: 0.0000811 AC XY: 6AN XY: 74024
GnomAD4 genome
AF:
AC:
15
AN:
151324
Hom.:
Cov.:
34
AF XY:
AC XY:
6
AN XY:
74024
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
GRIN2C-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 22, 2024 | The GRIN2C c.3594_3595delCA variant is predicted to result in premature protein termination (p.Tyr1198*). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.051% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at